av/cyclo-therapeutics--big.svg

NASDAQ:CYTHW

Cyclo Therapeutics, Inc.

  • Stock

USD

Last Close

1.37

17/05 20:00

Market Cap

38.93M

Beta: -

Volume Today

21.59K

Avg: 2.95K

PE Ratio

−1.53

PFCF: −2.83

Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
223.08K
-
408.09K
82.93%
592.67K
45.23%
553.78K
6.56%
484.31K
12.55%
443.88K
8.35%
329.58K
25.75%
240.27K
27.10%
232.67K
3.16%
240.96K
3.56%
254.42K
5.58%
average payables
171.27K
-
642.79K
275.30%
1.43M
123.12%
962.67K
32.88%
1.74M
-
1.74M
0%
average receivables
82.28K
-
90.13K
9.55%
68.31K
24.21%
89.85K
31.53%
108.40K
20.65%
105.11K
3.03%
149.99K
42.69%
147.14K
1.90%
325.44K
121.18%
297.04K
8.73%
88.69K
70.14%
book value per share
4.83
-
8.65
79.01%
6.66
22.93%
2.41
63.85%
1.59
33.98%
1.21
23.66%
0.77
36.58%
6.54
748.89%
2.46
62.36%
0.12
95.31%
0.29
152.55%
capex per share
-0.42
-
-0.34
18.52%
-0.75
116.80%
-0.01
98.02%
-0.01
35.46%
-0.00
61.97%
-0.00
69.91%
-0.03
2,950.19%
-0.00
89.37%
-0.00
32.93%
capex to depreciation
-1.06
-
-1.14
7.60%
-2.48
117.45%
-0.09
96.48%
-0.74
747.68%
-0.29
60.48%
-0.23
20.26%
-4.16
1,686.07%
-1.34
67.88%
-0.77
42.09%
capex to operating cash flow
-0.28
-
0.28
197.71%
0.21
23.51%
0.00
98.50%
0.00
29.29%
0.00
58.55%
0.00
78.35%
0.01
2,996.08%
0.00
75.90%
0.00
33.43%
capex to revenue
-0.09
-
-0.11
19.71%
-0.44
297.62%
-0.01
98.59%
-0.01
10.90%
-0.00
47.19%
-0.00
55.07%
-0.06
4,373.77%
-0.01
75.87%
-0.01
22.72%
cash per share
0.72
-
4.71
551.77%
3.28
30.40%
1.52
53.76%
1.76
16.41%
2.71
53.72%
2.29
15.57%
8.03
250.79%
2.61
67.53%
0.24
90.71%
0.57
133.63%
days of inventory on hand
206.48
-
770.02
272.92%
1.79K
132.45%
914.94
48.88%
1.29K
41.43%
1.45K
11.87%
1.17K
18.96%
1.31K
11.49%
531.87
59.33%
668.61
25.71%
1.10K
64.58%
days payables outstanding
630.09
-
2.59K
310.99%
6.69K
158.38%
9.14K
-
days sales outstanding
21.40
-
18.86
11.88%
21.37
13.30%
30.13
41.02%
27.35
9.23%
42.39
55.01%
66.13
55.99%
45.17
31.70%
124.08
174.72%
14.59
88.24%
41.50
184.43%
debt to assets
0.31
-
0.15
50.77%
0.16
5.44%
0.01
-
0.01
7.35%
0.01
36.08%
0.08
-
debt to equity
0.47
-
0.18
61.68%
0.20
10.72%
0.06
-
0.02
66.84%
0.01
41.35%
0.22
-
dividend yield
earnings yield
0.06
-
-0.02
129.91%
-0.08
350.42%
-0.16
87.87%
-0.15
1.95%
-0.07
57.21%
-0.19
185.40%
-1.28
590.82%
-0.60
53.06%
-1.69
180.66%
-0.77
54.28%
enterprise value
3.93M
-
30.76M
683.11%
29.83M
3.04%
26.28M
11.88%
23.94M
8.90%
63.19M
163.92%
38.60M
38.91%
-5.70M
114.75%
7.32M
228.51%
7.50M
2.47%
17.75M
136.70%
enterprise value over ebitda
6.79
-
-75.05
1,204.62%
-14.23
81.04%
-8.12
42.90%
-6.25
23.08%
-14.89
138.25%
-5.33
64.21%
0.64
111.92%
-0.51
180.95%
-0.48
7.42%
-0.89
85.97%
ev to operating cash flow
7.06
-
-48.74
790.53%
-14.99
69.24%
-8.91
40.60%
-7.82
12.22%
-19.82
153.50%
-5.86
70.44%
0.67
111.38%
-0.49
173.14%
-0.50
1.73%
-1.10
121.04%
ev to sales
2.32
-
19.63
746.01%
31.38
59.90%
17.49
44.27%
19.34
10.61%
62.47
222.96%
38.32
38.65%
-6.30
116.45%
4.62
173.21%
5.45
18.11%
16.49
202.53%
free cash flow per share
1.08
-
-1.59
248.13%
-4.29
169.03%
-4.67
9.04%
-4.26
8.81%
-3.90
8.38%
-5.42
38.89%
-5.37
0.89%
-2.36
56.10%
-2.38
0.71%
-0.99
58.28%
free cash flow yield
0.12
-
-0.02
120.83%
-0.08
213.06%
-0.11
39.47%
-0.12
12.03%
-0.05
59.92%
-0.16
226.80%
-1.24
674.66%
-0.63
48.80%
-1.67
164.54%
-0.62
62.74%
graham net net
-1.43
-
3.59
351.14%
2.09
41.61%
1.51
27.71%
0.88
41.96%
0.72
18.10%
-0.11
115.47%
5.82
5,330.80%
2.09
64.20%
-0.28
113.32%
0.06
121.50%
graham number
7.74
-
15.10
95.12%
26.09
72.72%
19.01
27.14%
13.80
27.41%
11.92
13.59%
10.46
12.29%
28.65
173.91%
11.15
61.08%
2.50
77.62%
2.84
13.70%
income quality
2.72
-
1.06
60.79%
0.78
26.78%
0.70
10.40%
0.80
14.36%
0.75
6.21%
0.87
16.74%
0.96
9.18%
1.05
9.97%
0.98
6.86%
0.81
17.51%
intangibles to total assets
0
-
0
0
0
0
0
0
0
0
0
0
interest coverage
6.25
-
-16.70
367.20%
-76.92
360.60%
-147.04
91.17%
103.76
-
interest debt per share
2.44
-
1.64
32.76%
1.40
14.73%
0.05
96.77%
0.04
-
0.12
181.47%
0.03
77.92%
-0.02
188.02%
0.06
367.78%
inventory turnover
1.77
-
0.47
73.18%
0.20
56.98%
0.40
95.63%
0.28
29.29%
0.25
10.61%
0.31
23.40%
0.28
10.30%
0.69
145.89%
0.55
20.45%
0.33
39.24%
invested capital
0.47
-
0.18
61.68%
0.20
10.72%
0.06
-
0.02
66.84%
0.01
41.35%
0.22
-
market cap
3.34M
-
32.35M
867.07%
30.92M
4.43%
27.24M
11.88%
25.21M
7.45%
65.41M
159.41%
41.33M
36.81%
6.96M
83.17%
23.76M
241.55%
9.04M
61.94%
25.96M
187.13%
net current asset value
-375.52K
-
2.13M
668.37%
1.51M
29.19%
1.29M
14.45%
952.75K
26.31%
844.28K
11.39%
780.82K
7.52%
10.31M
1,221.01%
15.59M
51.12%
677.89K
95.65%
3.83M
464.66%
net debt to ebitda
1.01
-
3.87
283.45%
0.52
86.58%
0.30
42.82%
0.33
11.77%
0.52
57.50%
0.38
27.83%
1.41
274.23%
1.16
18.13%
0.10
91.52%
0.41
318.11%
net income per share
0.55
-
-1.17
312.69%
-4.54
287.08%
-6.67
46.88%
-5.32
20.19%
-5.20
2.19%
-6.31
21.30%
-5.58
11.62%
-2.25
59.75%
-2.40
6.85%
-1.23
48.81%
operating cash flow per share
1.50
-
-1.25
183.39%
-3.54
183.42%
-4.66
31.60%
-4.25
8.73%
-3.90
8.26%
-5.42
38.99%
-5.34
1.48%
-2.36
55.89%
-2.37
0.76%
-0.99
58.24%
payables turnover
0.58
-
0.14
75.67%
0.05
61.30%
0.04
-
receivables turnover
17.06
-
19.36
13.48%
17.08
11.74%
12.11
29.09%
13.35
10.17%
8.61
35.49%
5.52
35.89%
8.08
46.42%
2.94
63.60%
25.02
750.50%
8.80
64.84%
research and ddevelopement to revenue
0.06
-
0.69
1,053.65%
1.24
79.08%
1.85
49.30%
2.68
44.70%
4.83
80.35%
6.75
39.59%
5.77
14.46%
6.54
13.32%
13.18
101.41%
return on tangible assets
0.07
-
-0.11
252.66%
-0.54
378.24%
-2.26
321.49%
-1.84
18.81%
-1.46
20.54%
-1.87
27.94%
-0.63
66.29%
-0.73
16.52%
-3.62
394.66%
-1.51
58.23%
revenue per share
4.56
-
3.10
31.93%
1.69
45.48%
2.37
40.29%
1.72
27.57%
1.24
28.00%
0.83
33.03%
0.56
31.82%
0.25
55.93%
0.22
13.21%
0.07
69.49%
roe
0.11
-
-0.14
218.82%
-0.68
402.22%
-2.77
306.36%
-3.35
20.88%
-4.29
28.13%
-8.20
91.25%
-0.85
89.59%
-0.91
6.92%
-20.80
2,178.92%
-4.22
79.73%
roic
0.09
-
-0.12
225.79%
-0.56
387.77%
-2.77
394.38%
-3.35
20.90%
-4.31
28.50%
-7.23
67.79%
-0.84
88.43%
-0.90
7.61%
-21.02
2,233.61%
-2.94
86.02%
sales general and administrative to revenue
0.38
-
0.98
159.22%
2.34
138.94%
1.76
24.80%
2.12
20.55%
2.40
13.29%
3.41
41.88%
4.07
19.36%
4.10
0.71%
5.67
38.45%
1.81
68.17%
shareholders equity per share
4.83
-
8.65
79.01%
6.66
22.93%
2.41
63.85%
1.59
33.98%
1.21
23.66%
0.77
36.58%
6.54
748.89%
2.46
62.36%
0.12
95.31%
0.29
152.55%
stock based compensation to revenue
0.02
-
0.10
332.67%
0.08
23.20%
0.08
2.97%
0.10
18.64%
0.08
13.99%
0.43
425.72%
0.30
30.73%
0.30
1.13%
0.37
25.71%
0.04
90.14%
tangible asset value
1.80M
-
4.37M
143.44%
3.75M
14.29%
1.53M
59.26%
1.15M
24.93%
992.52K
13.36%
935.98K
5.70%
10.45M
1,016.74%
15.67M
49.93%
734.54K
95.31%
4.76M
547.61%
tangible book value per share
4.83
-
8.65
79.01%
6.66
22.93%
2.41
63.85%
1.59
33.98%
1.21
23.66%
0.77
36.58%
6.54
748.89%
2.46
62.36%
0.12
95.31%
0.29
152.55%
working capital
419.93K
-
2.13M
408.26%
1.51M
29.19%
1.29M
14.45%
952.75K
26.31%
844.28K
11.39%
816.95K
3.24%
10.38M
1,170.30%
15.61M
50.37%
677.89K
95.66%
3.85M
467.97%

All numbers in USD (except ratios and percentages)